Visual Hallucinations and Headache in a Returning Adolescent Traveler

Abstract

Get full access to this article

View all access options for this article.

References

Hasan

Jamdar

Alalowi

Al Ageel

Beaiji

SM.

Dengue virus: a global human threat: review of literature. J Int Soc Prev Community Dent. 2016;6(1):1-6. doi:10.4103/2231-0762.175416.

Hendarto

Hadinegoro

SR.

Dengue encephalopathy. Acta Paediatr Jpn. 1992;34(3):350-357. doi:10.1111/j.1442-200x.1992.tb00971.x.

Epidemiological Alert: Increase in Dengue Cases in Central America and the Caribbean . Washington, DC: Pan American Health Organization; Geneva: World Organization of Health; 2023.

Guzman

Gubler

Izquierdo

Martinez

Halstead

SB.

Dengue infection. Nat Rev Dis Primers. 2016;2(1):16055. doi:10.1038/nrdp.2016.55.

Katzelnick

Gresh

Halloran

, et al. Antibody-dependent enhancement of severe dengue disease in humans. Science (New York, NY). 2017;358(6365):929-932. doi:10.1126/science.aan6836.

Tayal

Kabra

Lodha

Management of dengue: an updated review. Indian J Pediatr. 2023;90(2):168-177. doi:10.1007/s12098-022-04394-8.

Trivedi

Chakravarty

Neurological complications of dengue fever. Curr Neurol Neurosci Rep. 2022;22(8):515-529. doi:10.1007/s11910-022-01213-7.

Cochet

Calba

Jourdain

, et al. Autochthonous dengue in mainland France, 2022: geographical extension and incidence increase. Euro Surveill. 2022;27(44):2200818. doi:10.2807/1560-7917.Es.2022.27.44.2200818.

World Health Organization. Dengue and severe dengue. https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue. Accessed September 6, 2023.

10.

Centers for Disease Control and Prevention. Dengue-data and maps. https://www.cdc.gov/dengue/statistics-maps/data-and-maps.html. Accessed September 6, 2023.

11.

Haider

Asaduzzaman

Hasan

, et al. Bangladesh’s 2023 Dengue outbreak—age/gender-related disparity in morbidity and mortality and geographic variability of epidemic burdens. Int J Infect Dis. 2023;136:1-4. doi:10.1016/j.ijid.2023.08.026.

12.

Thomas

SJ.

Is new dengue vaccine efficacy data a relief or cause for concern?

NPJ Vaccines. 2023;8(1):55. doi:10.1038/s41541-023-00658-2.

13.

Paz-Bailey

Adams

Wong

, et al. Dengue vaccine: recommendations of the advisory committee on immunization practices, United States, 2021. MMWR Recomm Rep. 2021;70(6):1-16. doi:10.15585/mmwr.rr7006a1.

14.

World Health Organization. Vaccines and immunization: dengue. https://www.who.int/news-room/questions-and-answers/item/dengue-vaccines. Accessed November 10, 2023.

15.

Capeding

Tran

Hadinegoro

, et al. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial. Lancet. 2014;384(9951):1358-1365. doi:10.1016/s0140-6736(14)61060-6.

16.

Villar

LÁ

Rivera-Medina

Arredondo-García

, et al. Safety and immunogenicity of a recombinant tetravalent dengue vaccine in 9-16 year olds: a randomized, controlled, phase II trial in Latin America. Pediatr Infect Dis J. 2013;32(10):1102-1109. doi:10.1097/INF.0b013e31829b8022.

17.

Biswal

Reynales

Saez-Llorens

, et al. Efficacy of a tetravalent dengue vaccine in healthy children and adolescents. N Engl J Med. 2019;381(21):2009-2019. doi:10.1056/NEJMoa1903869.

18.

Rivera

Biswal

Sáez-Llorens

, et al. Three-year efficacy and safety of Takeda’s dengue vaccine candidate (TAK-003). Clin Infect Dis. 2022;75(1):107-117. doi:10.1093/cid/ciab864.

19.

World Health Organization. WHO recommends R21/matrix-M vaccine for malaria prevention in updated advice on immunization. https://www.who.int/news/item/02-10-2023-who-recommends-r21-matrix-m-vaccine-for-malaria-prevention-in-updated-advice-on-immunization. Accessed November 10, 2023.

20.

Qdenga. European Medicines Agency. https://www.ema.europa.eu/en/medicines/human/EPAR/qdenga. Accessed November 10, 2023.

21.

Portal do Butantan. Butantan’s dengue vaccine has 79.6% efficacy, partial results from 2-year follow-up show. https://butantan.gov.br/noticias/butantan%27s-dengue-vaccine-has-79.6-efficacy-partial-results-from-2-year-follow-up-show. Accessed 10 November 10, 2023.

22.

Cristiane

Marzia

PS.

Diagnosis criteria of dengue encephalitis. Arq Neuropsiquiatr. 2014;72(3):263. doi:10.1590/0004-282x20130251.

23.

Wong

Adams

Durbin

, et al. Dengue: a growing problem with new interventions. Pediatrics. 2022;149(6):e2021055522. doi:10.1542/peds.2021-055522.